Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Small Cell Lung Cancer (SCLC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04358237
What this trial is testing

Lurbinectedin (PM01183) Combined With Pembrolizumab in Small Cell Lung Cancer.

Who this might be right for
Small Cell Lung Carcinoma
Antonio Calles Blanco 28
Testing effectiveness (Phase 2)Study completedNCT04010357
What this trial is testing

Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC

Who this might be right for
Small-cell Lung CancerLarge Cell Neuroendocrine Carcinoma of the LungExtrapulmonary Small Cell Carcinoma
Case Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)Study completedNCT01497873
What this trial is testing

Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Chong Kun Dang Pharmaceutical 164
Testing effectiveness (Phase 2)WithdrawnNCT00104754
What this trial is testing

Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology
Large-scale testing (Phase 3)Ended earlyNCT00535275
What this trial is testing

NSCLC Relapse Therapy After Surgery and Peri-operative Chemotherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Intergroupe Francophone de Cancerologie Thoracique 88
Early research (Phase 1)Study completedNCT00620295
What this trial is testing

Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+6 more
Masonic Cancer Center, University of Minnesota 17
Large-scale testing (Phase 3)Active Not RecruitingNCT06500026
What this trial is testing

A Study Comparing BL-B01D1 With Topotecan in Patients With Recurrent Small Cell Lung Cancer(PANKU-Lung03)

Who this might be right for
Small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 722
Testing effectiveness (Phase 2)Looking for participantsNCT04919382
What this trial is testing

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaMetastatic Lung Small Cell CarcinomaRecurrent Lung Small Cell Carcinoma+3 more
Dwight Owen 56
Early research (Phase 1)WithdrawnNCT01820091
What this trial is testing

Phase 1 Study of Fusilev® to Prevent or Reduce Mucositis in Patients With Non-Small Cell Lung Cancer Receiving Folotyn®

Who this might be right for
Non-Small Cell Lung Cancer
Acrotech Biopharma Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06681220
What this trial is testing

Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC

Who this might be right for
Relapsed Small Cell Lung CancerRecurrent Small Cell Lung Cancer
VA Office of Research and Development 166
Early research (Phase 1)Study completedNCT00002625
What this trial is testing

Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Esophageal CancerLung CancerLymphoma
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Ended earlyNCT05420636
What this trial is testing

Iadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NET

Who this might be right for
Small-cell Lung CancerNeuroendocrine Carcinoma
Fox Chase Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00064012
What this trial is testing

Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Wisconsin, Madison 4
Testing effectiveness (Phase 2)Looking for participantsNCT06463665
What this trial is testing

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

Who this might be right for
Advanced Non-squamous Non-small-cell Lung CancerAdvanced Squamous Non-Small Cell Lung CarcinomaMetastatic Non-squamous Non Small Cell Lung Cancer+5 more
Genelux Corporation 142
Early research (Phase 1)Looking for participantsNCT06484816
What this trial is testing

TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies

Who this might be right for
Non Small Cell Lung CancerAdvanced Solid TumorHematologic Malignancy
Shenzhen TargetRx Co., Ltd. 90
Early research (Phase 1)Active Not RecruitingNCT05353439
What this trial is testing

Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaLimited Stage Lung Small Cell CarcinomaPlatinum-Resistant Lung Small Cell Carcinoma+3 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT00101413
What this trial is testing

BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC)

Who this might be right for
CancerCarcinoma, Non-Small Cell Lung
Bayer 52
Testing effectiveness (Phase 2)Study completedNCT01173523
What this trial is testing

Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
David M. Jackman, MD 25
Not applicableStudy completedNCT00433407
What this trial is testing

T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors

Who this might be right for
Breast CancerLung CancerOvarian Cancer+3 more
Jonsson Comprehensive Cancer Center 12
Not applicableStudy completedNCT00874211
What this trial is testing

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Who this might be right for
Breast CancerLung CancerMetastatic Cancer+4 more
SWOG Cancer Research Network 3,571
Next Page